CME Ownership
| CME Stock | USD 274.64 0.36 0.13% |
Shares in Circulation | First Issued 2001-06-30 | Previous Quarter 360.1 M | Current Value 360.2 M | Avarage Shares Outstanding 294 M | Quarterly Volatility 79.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. CME Stock Ownership Analysis
About 92.0% of the company shares are held by institutions such as insurance companies. The book value of CME was currently reported as 75.16. The company recorded earning per share (EPS) of 9.93. CME Group last dividend was issued on the 9th of June 2025. The entity had 5:1 split on the 23rd of July 2012. CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. It employs 3480 people. For more info on CME Group please contact the company at 312 930 1000 or go to https://www.cmegroup.com.Besides selling stocks to institutional investors, CME also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different CME's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align CME's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
CME Quarterly Liabilities And Stockholders Equity |
|
CME Insider Trades History
Less than 1% of CME Group are currently held by insiders. Unlike CME's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against CME's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of CME's insider trades
CME Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as CME is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CME Group backward and forwards among themselves. CME's institutional investor refers to the entity that pools money to purchase CME's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Capital Research & Mgmt Co - Division 3 | 2025-03-31 | 4.4 M | Northern Trust Corp | 2025-03-31 | 3.8 M | Arrowstreet Capital Limited Partnership | 2025-03-31 | 3.6 M | Fidelity International Ltd | 2025-03-31 | 3.6 M | Franklin Resources Inc | 2025-03-31 | 3.4 M | Royal Bank Of Canada | 2025-03-31 | 3.3 M | Goldman Sachs Group Inc | 2025-03-31 | 3.1 M | Ubs Group Ag | 2025-03-31 | 3 M | Mitsubishi Ufj Asset Management Co.,ltd | 2025-03-31 | 2.9 M | Vanguard Group Inc | 2025-03-31 | 34.6 M | Blackrock Inc | 2025-03-31 | 32.6 M |
CME Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CME insiders, such as employees or executives, is commonly permitted as long as it does not rely on CME's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CME insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mccourt Timothy Francis over six months ago Disposition of tradable shares by Mccourt Timothy Francis of CME at 206.775 subject to Rule 16b-3 | ||
Mccourt Timothy Francis over a year ago Disposition of tradable shares by Mccourt Timothy Francis of CME at 217.5 subject to Rule 16b-3 | ||
Julie Winkler over a year ago Acquisition by Julie Winkler of 3808 shares of CME subject to Rule 16b-3 | ||
Julie Winkler over a year ago Payment of 1513 shares by Julie Winkler of CME subject to Rule 16b-3 |
CME's latest congressional trading
Congressional trading in companies like CME Group, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in CME by those in governmental positions are based on the same information available to the general public.
| 2025-06-23 | Representative Jefferson Shreve | Acquired $15K to $50K | Verify | ||
| 2025-05-08 | Representative Rob Bresnahan | Acquired Under $15K | Verify | ||
| 2025-04-11 | Representative Carol Devine Miller | Acquired Under $15K | Verify | ||
| 2024-02-01 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2023-02-02 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2023-02-01 | Senator Thomas R Carper | Acquired Under $15K | Verify |
CME Outstanding Bonds
CME issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CME Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CME bonds can be classified according to their maturity, which is the date when CME Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| CME GROUP INC Corp BondUS12572QAF28 | View | |
| CME GROUP INC Corp BondUS12572QAH83 | View | |
| CME GROUP INC Corp BondUS12572QAJ40 | View | |
| CME 265 15 MAR 32 Corp BondUS12572QAK13 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
CME Corporate Filings
F4 | 26th of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 9th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 7th of May 2025 Other Reports | ViewVerify | |
F5 | 5th of May 2025 The annual filing required by the Securities and Exchange Commission (SEC) from company insiders or beneficial owners | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Financial Exchanges & Data space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.115 | Dividend Share 4.7 | Earnings Share 9.93 | Revenue Per Share | Quarterly Revenue Growth 0.104 |
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.